Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 6Phase 1/2 5Phase NA 2Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2CNS 1

Conditions

Carcinoma, Hepatocellular 12Refractory Solid Tumors 2Recurrence 2Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Neurologic Manifestations 1Neoplasm Metastasis 1Meningeal Carcinomatosis 1Liver Neoplasms 1Kidney Neoplasms 1HCC 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1

Interventions

Exercise 112Surveys and Questionnaires 56Early Intervention, Educational 49Standard of Care 46Methods 46Magnetic Resonance Spectroscopy 45Blood Specimen Collection 44Acupuncture Therapy 44Educational Status 43Radiotherapy 36Mammography 36Control Groups 31Therapeutics 29Counseling 29Psychiatric Rehabilitation 27Cyclophosphamide 27Sentinel Lymph Node Biopsy 25Biopsy 24Yoga 20Mastectomy, Segmental 20Resistance Training 19Palliative Care 18Neoadjuvant Therapy 18High-Energy Shock Waves 18Doxorubicin 18Cognitive Behavioral Therapy 18Magnetic Resonance Imaging 17Practice Guidelines as Topic 16Paclitaxel 16Trastuzumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms × Sorafenib × Clear all
NCT00964743 2013-09-09

Depocyt® With Sorafenib in Neoplastic Meningitis

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Terminated
2 enrolled 6 charts
BreastCNS

Breast Neoplasms, Neurologic Manifestations, Meningeal Carcinomatosis

NCT00544167 2013-04-01

Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer

SCRI Development Innovations, LLC

Phase NA Completed
45 enrolled 5 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡